These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20039217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
    Marley K, Helfand SC, Edris WA, Mata JE, Gitelman AI, Medlock J, Séguin B.
    BMC Vet Res; 2013 Jan 18; 9():15. PubMed ID: 23331343
    [Abstract] [Full Text] [Related]

  • 3. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
    Stendel R, Picht T, Schilling A, Heidenreich J, Loddenkemper C, Jänisch W, Brock M.
    Anticancer Res; 2004 Jan 18; 24(2C):1143-7. PubMed ID: 15154639
    [Abstract] [Full Text] [Related]

  • 4. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I, Sigrist B, Hillinger S, Lardinois D, Stahel R, Weder W, Hopkins-Donaldson S.
    Lung Cancer; 2007 Jun 18; 56(3):327-36. PubMed ID: 17383050
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML, Redmond HP, Bouchier-Hayes DJ.
    J Surg Res; 2001 Dec 18; 101(2):111-9. PubMed ID: 11735264
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    Koldehoff M, Zakrzewski JL.
    Int J Antimicrob Agents; 2004 Nov 18; 24(5):491-5. PubMed ID: 15519483
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
    Braumann C, Schoenbeck M, Menenakos C, Kilian M, Jacobi CA.
    Clin Exp Metastasis; 2005 Nov 18; 22(1):77-83. PubMed ID: 16132581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
    Walters DK, Muff R, Langsam B, Gruber P, Born W, Fuchs B.
    Invest New Drugs; 2007 Aug 18; 25(4):305-12. PubMed ID: 17458504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.